Valuation: Compugen Ltd.

Market Cap 174M 159M 146M 133M 250M 16.14B 262M 1.78B 708M 8.82B 654M 640M 27.67B P/E 2026 *
-6.51x
P/E 2027 * -6.62x
Enterprise Value 174M 159M 146M 133M 250M 16.14B 262M 1.78B 708M 8.82B 654M 640M 27.67B EV / Sales 2026 *
14.4x
EV / Sales 2027 * 22.8x
Free-Float
99.61%
Yield 2026 *
-
Yield 2027 * -
1 day-2.13%
1 week-12.38%
Current month-7.07%
1 month-13.21%
3 months-29.64%
6 months-29.50%
Current year+20.26%
1 week 1.81
Extreme 1.81
2.07
1 month 1.81
Extreme 1.81
2.15
Current year 1.51
Extreme 1.51
3.24
1 year 1.43
Extreme 1.43
3.24
3 years 0.62
Extreme 0.62
3.24
5 years 0.51
Extreme 0.51
4.88
10 years 0.51
Extreme 0.51
19.9
Manager TitleAgeSince
Chief Executive Officer - 2025-09-22
Director of Finance/CFO 42 2024-08-14
Chief Operating Officer 49 2023-12-31
Director TitleAgeSince
Chairman 59 2025-09-22
Director/Board Member 60 2018-06-10
Director/Board Member 70 2018-06-10
Date Insider Type Main position Quantity % Market Cap. Importance
7/29/26 Free

Chief Operating Officer

70,000 0.0740%
7/29/26 Free

Chairman

100,000 0.1058%
7/29/26 Free

Chief Financial Officer

45,500 0.0481%
Change 5-day change 1-year change 3-year change Capi.($)
-2.13%-12.38%+20.26%+177.99% 174M
-2.49%-3.76%+53.38%+62.10% 63.66B
-0.63%-2.91%+6.55%+89.34% 58.56B
-2.37%-2.22%+21.77%+84.58% 54.19B
-2.19%-6.15%+12.43%+111.40% 44.66B
-1.89%-7.28%+9.30%+18.50% 40.51B
-0.93%-0.47%+19.34%+41.83% 36.27B
+1.11%-6.44%+127.46%+675.37% 34.87B
-0.80%+0.61%+76.27%+61.80% 32.26B
-2.17%+16.65%-28.89%+479.93% 31.01B
Average -1.45%-2.23%+31.79%+180.28% 40B
Weighted average by Cap. -1.48%-1.86%+31.82%+155.15%

Financials

2026 *2027 *
Net sales 12.07M 11M 10.13M 9.22M 17.29M 1.12B 18.17M 123M 49.02M 611M 45.3M 44.35M 1.92B 7.65M 6.97M 6.42M 5.84M 10.96M 708M 11.51M 78.14M 31.06M 387M 28.7M 28.1M 1.21B
Net income -26.84M -24.45M -22.53M -20.49M -38.45M -2.49B -40.41M -274M -109M -1.36B -101M -98.6M -4.26B -27.04M -24.63M -22.69M -20.64M -38.73M -2.5B -40.7M -276M -110M -1.37B -101M -99.31M -4.29B
Net Debt - -
Projected Income Statement - Annual - Compugen Ltd.
Logo Compugen Ltd.
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Employees
75
Date Price Change Volume
26-11-20 $1.840 -2.13% 188,249
26-11-19 $1.880 -4.08% 262,638
26-11-18 $1.960 -2.97% 146,094
26-11-17 $2.020 -0.98% 197,679
26-11-16 $2.040 -2.86% 250,429
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Compugen Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.840USD
Average target price
4.800USD
Spread / Average Target
+160.87%
  1. Stock Market
  2. Stocks
  3. CGEN Stock